The estimated Net Worth of Scott Lish is at least 5.64 百万$ dollars as of 6 August 2024. Mr Lish owns over 71,500 units of Alphatec Inc stock worth over 3,165,692$ and over the last 4 years he sold ATEC stock worth over 2,473,963$.
Mr has made over 12 trades of the Alphatec Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 71,500 units of ATEC stock worth 200,200$ on 6 August 2024.
The largest trade he's ever made was exercising 71,500 units of Alphatec Inc stock on 6 August 2024 worth over 200,200$. On average, Mr trades about 15,360 units every 70 days since 2020. As of 6 August 2024 he still owns at least 580,861 units of Alphatec Inc stock.
You can see the complete history of Mr Lish stock trades at the bottom of the page.
Scott Lish is the Sr. VP of R&D at Alphatec Inc.
Mr Lish is 40, he's been the Sr. VP of R&D of Alphatec Inc since . There are 26 older and no younger executives at Alphatec Inc. The oldest executive at Alphatec Holdings Inc is Ward Woods, 77, who is the Independent Director.
Scott's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.
Over the last 18 years, insiders at Alphatec Inc have traded over 1,216,108,242$ worth of Alphatec Inc stock and bought 24,460,197 units worth 141,338,962$ . The most active insiders traders include Mortimer Iii Berkowitz、John Foster、Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of 1,610,824$. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth 201,600$.
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
Alphatec Inc executives and other stock owners filed with the SEC include: